The company received investment and the transaction was led by OrbiMed Advisors LLC, and included participation from new investors Cathay Capital Private Equity SAS, Supernova, Jinxiu Zhonghe (Beijing) Capital Management Co., Ltd., Hunan Caixin Capital Management Co., Ltd., Hunan Xingxiang Investment Holding Group Co., Ltd., Hunan Agricultural Development Fund, Caixin Capital, and other local funds.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.55 CNY | +1.67% | +1.85% | +7.24% |
1st Jan change | Capi. | |
---|---|---|
+7.24% | 685M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- 600479 Stock
- News ZhuZhou QianJin Pharmaceutical Co.,Ltd
- Hunan Xinhexin Bio-Pharmaceutical Co., Ltd. announces tranche update